131 related articles for article (PubMed ID: 1970487)
21. Carrier detection in the Wiskott Aldrich syndrome.
Fearon ER; Kohn DB; Winkelstein JA; Vogelstein B; Blaese RM
Blood; 1988 Nov; 72(5):1735-9. PubMed ID: 3263154
[TBL] [Abstract][Full Text] [Related]
22. A novel strategy for the investigation of clonality in precancerous disease states and early stages of tumor progression.
Sternlicht M; Mirell C; Safarians S; Barsky SH
Biochem Biophys Res Commun; 1994 Mar; 199(2):511-8. PubMed ID: 7510955
[TBL] [Abstract][Full Text] [Related]
23. X-chromosome inactivation in the Wiskott-Aldrich syndrome: a marker for detection of the carrier state and identification of cell lineages expressing the gene defect.
Greer WL; Kwong PC; Peacocke M; Ip P; Rubin LA; Siminovitch KA
Genomics; 1989 Jan; 4(1):60-7. PubMed ID: 2563352
[TBL] [Abstract][Full Text] [Related]
24. Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms.
Anger B; Janssen JW; Schrezenmeier H; Hehlmann R; Heimpel H; Bartram CR
Leukemia; 1990 Apr; 4(4):258-61. PubMed ID: 1973205
[TBL] [Abstract][Full Text] [Related]
25. Myeloproliferative disorders: usefulness of X-linked probes in diagnosis.
Taylor KM; Shetta M; Talpaz M; Kantarjian HM; Hardikar S; Chinault AC; McCredie KB; Spitzer G
Leukemia; 1989 Jun; 3(6):419-22. PubMed ID: 2566725
[TBL] [Abstract][Full Text] [Related]
26. Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis.
Schulte HM; Oldfield EH; Allolio B; Katz DA; Berkman RA; Ali IU
J Clin Endocrinol Metab; 1991 Dec; 73(6):1302-8. PubMed ID: 1720126
[TBL] [Abstract][Full Text] [Related]
27. Defective natural killer (NK) cell-mediated cytotoxicity does not imply clonal involvement of NK cells in myelodysplastic syndromes.
Ogata K; Fujii H; Yokose N; An E; Tamura H; Kamikubo K; Dan K; Hamaguchi H; Sakamaki H; Onozawa Y
Br J Haematol; 1994 Jun; 87(2):396-8. PubMed ID: 7947284
[TBL] [Abstract][Full Text] [Related]
28. Clinically nonfunctioning pituitary tumors are monoclonal in origin.
Alexander JM; Biller BM; Bikkal H; Zervas NT; Arnold A; Klibanski A
J Clin Invest; 1990 Jul; 86(1):336-40. PubMed ID: 1973174
[TBL] [Abstract][Full Text] [Related]
29. Clonality in myelodysplastic syndromes.
Weimar IS; Bourhis JH; De Gast GC; Gerritsen WR
Leuk Lymphoma; 1994 Apr; 13(3-4):215-21. PubMed ID: 7914126
[TBL] [Abstract][Full Text] [Related]
30. Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction.
Gilliland DG; Blanchard KL; Levy J; Perrin S; Bunn HF
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6848-52. PubMed ID: 1862109
[TBL] [Abstract][Full Text] [Related]
31. Bam HI restriction fragment length polymorphisms for hypoxanthine-guanine phosphoribosyltransferase (HPRT) gene of carriers and controls of HPRT deficiency in Japan.
Igarashi T; Ikegami H; Yamazaki H; Minami M
Acta Paediatr Jpn; 1990 Feb; 32(1):12-5. PubMed ID: 1970211
[TBL] [Abstract][Full Text] [Related]
32. Clonal nature of Philadelphia chromosome-positive and -negative chronic myelogenous leukemia by DNA hybridization analyses.
Yoffe G; Chinault AC; Talpaz M; Blick MB; Kantarjian HM; Taylor K; Spitzer G
Exp Hematol; 1987 Aug; 15(7):725-8. PubMed ID: 2440709
[TBL] [Abstract][Full Text] [Related]
33. Clonal studies of CD3- lymphoproliferative disease of granular lymphocytes.
Nash R; McSweeney P; Zambello R; Semenzato G; Loughran TP
Blood; 1993 May; 81(9):2363-8. PubMed ID: 8097633
[TBL] [Abstract][Full Text] [Related]
34. A TaqI RFLP in the region of the HPRT locus.
Renwick P; Raybould M; Birley A; Hultén M
Nucleic Acids Res; 1991 Aug; 19(16):4576. PubMed ID: 1679540
[No Abstract] [Full Text] [Related]
35. Clonal remissions in acute myeloid leukaemia are commonly associated with features of trilineage myelodysplasia during remission.
Jowitt SN; Liu Yin JA; Saunders MJ; Lucas GS
Br J Haematol; 1993 Dec; 85(4):698-705. PubMed ID: 7918032
[TBL] [Abstract][Full Text] [Related]
36. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
Bernell P; Jacobsson B; Nordgren A; Hast R
Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
[TBL] [Abstract][Full Text] [Related]
37. Clonal hematopoiesis demonstrated by X-linked DNA polymorphisms after allogeneic bone marrow transplantation.
Turhan AG; Humphries RK; Phillips GL; Eaves AC; Eaves CJ
N Engl J Med; 1989 Jun; 320(25):1655-61. PubMed ID: 2566916
[TBL] [Abstract][Full Text] [Related]
38. Carrier detection of partial hypoxanthine-guanine phosphoribosyltransferase deficiency by analysis with BamHI restriction fragment length polymorphisms and oligonucleotide probes.
Igarashi T; Kamoshita S
Pediatr Res; 1990 Apr; 27(4 Pt 1):417-21. PubMed ID: 1971437
[TBL] [Abstract][Full Text] [Related]
39. Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes.
Asano H; Ohashi H; Ichihara M; Kinoshita T; Murate T; Kobayashi M; Saito H; Hotta T
Blood; 1994 Jul; 84(2):588-94. PubMed ID: 7517721
[TBL] [Abstract][Full Text] [Related]
40. Myeloid but not lymphoid cells carry the 5q deletion: polymerase chain reaction analysis of loss of heterozygosity using mini-repeat sequences on highly purified cell fractions.
Kroef MJ; Fibbe WE; Mout R; Jansen RP; Haak HL; Wessels JW; Van Kamp H; Willemze R; Landegent JE
Blood; 1993 Apr; 81(7):1849-54. PubMed ID: 8461471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
